Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 11-03-28 |
Sian Bigora
FOU | Founder | 63 | 11-03-28 |
David Young
FOU | Founder | 71 | 11-03-28 |
Patrick Lin
FOU | Founder | 58 | 11-03-28 |
George Ng
CEO | Chief Executive Officer | 49 | 23-08-07 |
Jim Stanker
DFI | Director of Finance/CFO | 67 | 18-09-04 |
Weifei Ye
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kayla Parks
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Mary Nyberg
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 23-08-07 |
James Neal
BRD | Director/Board Member | 68 | 22-07-15 |
Justin Yorke
CHM | Chairman | 58 | 17-10-01 |
Patrick Lin
FOU | Founder | 58 | 11-03-28 |
David Young
FOU | Founder | 71 | 11-03-28 |
Director/Board Member | 66 | 22-07-10 | |
Geraldine Pannu
BRD | Director/Board Member | 54 | 20-02-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,862,896 | 2,536,002 ( 88.58 %) | 5,000 ( 0.1746 %) | 88.58 % |
Company contact information
Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive Suite 106
21076, Hanover
+
http://www.processapharma.comSector
1st Jan change | Capi. | |
---|---|---|
+32.36% | 694B | |
+30.77% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.77% | 239B | |
+9.13% | 209B | |
-3.97% | 209B | |
+9.27% | 169B |